By looking at the immunological trajectories of the various outcomes for COVID-19 in the general population, antibody levels for both IgM and IgG were significantly lower in non-survivors, suggesting that the antibody response contributes to recovery [44]. The gene discussed is CD40LG; the disease is COVID-19.